Skip to main content
Erschienen in: Acta Diabetologica 6/2017

06.04.2017 | Original Article

Determinants of glomerular filtration rate following bariatric surgery in individuals with severe, otherwise uncomplicated, obesity: an observational, prospective study

verfasst von: Marta Seghieri, Edoardo Vitolo, Livia Giannini, Eleonora Santini, Chiara Rossi, Antonio Salvati, Anna Solini

Erschienen in: Acta Diabetologica | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Aims

Obesity-induced nephropathy is an established clinical entity arising from a “maladaptive” response to lipid accumulation at the nephron level. Bariatric surgery positively affects renal function, reducing or increasing glomerular filtration rate (GFR) in subjects with hyperfiltration and renal impairment, respectively. The effect of this surgery in patients with normal estimated GFR (eGFR) is less clear.

Methods

A complete clinical and biochemical assessment of 135 severely obese, otherwise healthy subjects, was obtained before Roux-en-Y gastric bypass (RYGB). All subjects underwent an OGTT with plasma glucose and insulin determinations. Follow-up data were recorded at 6, 12, 24 and 48 months after intervention.

Results

Baseline eGFR was 98.2 ± 13.6 ml/min/1.73 m2; hyperfiltration (>120 ml/min/1.73 m2) was present in 7% of the cohort. No eGFR variation over the follow-up emerged, except at the last visit (−3.6 ± 1.4 ml/min/1.73 m2 at month 48, p = 0.01 vs baseline). In the univariate analysis, the renal performance at 48 months was inversely related to baseline eGFR (r = −0.17, p = 0.04) and plasma triglycerides (r = −0.04, p = 0.05). Fasting and OGTT-derived variables did not impact eGFR. By multiple regression analysis, eGFR time course was independently predicted only by baseline eGFR (p = 0.03). Interestingly, patients having a baseline eGFR >100 ml/min/1.73 m2 (median value) showed, after 48 months, an average loss of −8.3 ± 2.2 ml/min/1.73 m2, while those with eGFR <100 exhibited a slight increase (+1.8 ± 2.3 ml/min/1.73 m2, p < 0.01).

Conclusions

Long-term data confirm the safety of RYGB on renal function. Interestingly, a subtle hyperfiltration, i.e., occurring in high-normal range of eGFR, is attenuated by surgical procedure. Lastly, high serum triglycerides may track an unfavorable renal outcome.
Literatur
4.
Zurück zum Zitat D’Agati VD, Chagnac A, de Vries AP, Levi M, Porrini E, Herman-Edelstein M (2016) Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol 12:453–471. doi:10.1038/nrneph.2016.75 CrossRefPubMed D’Agati VD, Chagnac A, de Vries AP, Levi M, Porrini E, Herman-Edelstein M (2016) Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol 12:453–471. doi:10.​1038/​nrneph.​2016.​75 CrossRefPubMed
5.
Zurück zum Zitat Chang Y, Ryu S, Choi Y, Zhang Y, Cho J, Kwon MJ (2016) Metabolically healthy obesity and development of chronic kidney disease: a cohort study. Ann Int Med 164:305–312. doi:10.7326/M15-1323 CrossRefPubMed Chang Y, Ryu S, Choi Y, Zhang Y, Cho J, Kwon MJ (2016) Metabolically healthy obesity and development of chronic kidney disease: a cohort study. Ann Int Med 164:305–312. doi:10.​7326/​M15-1323 CrossRefPubMed
6.
Zurück zum Zitat Luaces M, Martínez-Martínez E, Medina M, Miana M, González N, Fernández-Pérez C (2012) The impact of bariatric surgery on renal and cardiac functions in morbidly obese patients. Nephrol Dial Transplant 27:iv53–iv57. doi:10.1093/ndt/gfs529 CrossRefPubMed Luaces M, Martínez-Martínez E, Medina M, Miana M, González N, Fernández-Pérez C (2012) The impact of bariatric surgery on renal and cardiac functions in morbidly obese patients. Nephrol Dial Transplant 27:iv53–iv57. doi:10.​1093/​ndt/​gfs529 CrossRefPubMed
7.
Zurück zum Zitat Serpa Neto A, Bianco Rossi FM, Dal Moro Amarante R, Alves Buriti N, Cunha Barbosa Saheb G, Rossi M (2009) Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients. J Nephrol 22:637–646PubMed Serpa Neto A, Bianco Rossi FM, Dal Moro Amarante R, Alves Buriti N, Cunha Barbosa Saheb G, Rossi M (2009) Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients. J Nephrol 22:637–646PubMed
9.
Zurück zum Zitat Navarro-Díaz M, Serra A, Romero R et al (2006) Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol 17:S213–S217. doi:10.1681/ASN.2006080917 CrossRefPubMed Navarro-Díaz M, Serra A, Romero R et al (2006) Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol 17:S213–S217. doi:10.​1681/​ASN.​2006080917 CrossRefPubMed
13.
Zurück zum Zitat Delanaye P, Rademecker RP, Rorive M, Depas G, Krzesinski JM (2005) Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. Nephrol Dial Transplant 20:2024–2028. doi:10.1093/ndt/gfh983 CrossRefPubMed Delanaye P, Rademecker RP, Rorive M, Depas G, Krzesinski JM (2005) Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. Nephrol Dial Transplant 20:2024–2028. doi:10.​1093/​ndt/​gfh983 CrossRefPubMed
14.
Zurück zum Zitat Vitolo E, Santini E, Salvati A et al (2016) Metabolic and hormonal determinants of glomerular filtration rate and renal hemodynamics in severely obese individuals. Obes Facts 9:310–320. doi:10.1159/000446965 CrossRefPubMed Vitolo E, Santini E, Salvati A et al (2016) Metabolic and hormonal determinants of glomerular filtration rate and renal hemodynamics in severely obese individuals. Obes Facts 9:310–320. doi:10.​1159/​000446965 CrossRefPubMed
16.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
17.
Zurück zum Zitat Hermans MP, Levy JC, Morris RJ, Turner RC (1999) Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48:1779–1786CrossRefPubMed Hermans MP, Levy JC, Morris RJ, Turner RC (1999) Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48:1779–1786CrossRefPubMed
18.
Zurück zum Zitat Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548CrossRefPubMed Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548CrossRefPubMed
19.
Zurück zum Zitat Pacini G, Mari A (2003) Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab 17:305–322CrossRefPubMed Pacini G, Mari A (2003) Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab 17:305–322CrossRefPubMed
20.
Zurück zum Zitat Seltzer HS, Allen EW, Herron AL Jr, Brennan MT (1967) Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46:323–335CrossRefPubMedPubMedCentral Seltzer HS, Allen EW, Herron AL Jr, Brennan MT (1967) Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46:323–335CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150CrossRef
26.
Zurück zum Zitat Serra A, Esteve A, Navarro-Díaz M, López D, Bancu I, Romero R (2015) Long-term normal renal function after drastic weight reduction in patients with obesity-related glomerulopathy. Obes Facts 8:188–199. doi:10.1159/000431027 CrossRefPubMed Serra A, Esteve A, Navarro-Díaz M, López D, Bancu I, Romero R (2015) Long-term normal renal function after drastic weight reduction in patients with obesity-related glomerulopathy. Obes Facts 8:188–199. doi:10.​1159/​000431027 CrossRefPubMed
27.
Zurück zum Zitat Zakaria AS, Rossetti L, Cristina M et al (2016) Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis 12:587–595. doi:10.1016/j.soard.2015.10.062 CrossRefPubMed Zakaria AS, Rossetti L, Cristina M et al (2016) Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis 12:587–595. doi:10.​1016/​j.​soard.​2015.​10.​062 CrossRefPubMed
29.
Zurück zum Zitat Navaneethan SD, Malin SK, Arrigain S, Kashyap SR, Kirwan JP, Schauer PR (2015) Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study. Am J Kidney Dis 65:345–347. doi:10.1053/j.ajkd.2014.09.018 CrossRefPubMed Navaneethan SD, Malin SK, Arrigain S, Kashyap SR, Kirwan JP, Schauer PR (2015) Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study. Am J Kidney Dis 65:345–347. doi:10.​1053/​j.​ajkd.​2014.​09.​018 CrossRefPubMed
32.
Zurück zum Zitat Moorhead JF, Chan MK, El-Nahas M, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2:1309–1311CrossRefPubMed Moorhead JF, Chan MK, El-Nahas M, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2:1309–1311CrossRefPubMed
Metadaten
Titel
Determinants of glomerular filtration rate following bariatric surgery in individuals with severe, otherwise uncomplicated, obesity: an observational, prospective study
verfasst von
Marta Seghieri
Edoardo Vitolo
Livia Giannini
Eleonora Santini
Chiara Rossi
Antonio Salvati
Anna Solini
Publikationsdatum
06.04.2017
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 6/2017
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-017-0988-8

Weitere Artikel der Ausgabe 6/2017

Acta Diabetologica 6/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.